Loading

Aguarde, carregando...

Logo Câmara Municipal de Água Azul do Norte, Pa

Viagra capsules

Dirk B. Robertson MD

  • Professor of Clinical Dermatology, Department of Dermatology
  • Emory University School of Medicine, Atlanta

https://atlantaskinsurgery.com/physicians/dr-robertson

The pulsating iliac vessels could be seen endoscopically as the ureters cross the pelvic brim and angulate posteriorly in the proximal portion impotence urology buy viagra capsules master card. The kidneys lie on the diaphragm erectile dysfunction houston order generic viagra capsules, and thus they are affected by the respiratory movements erectile dysfunction after drug use trusted 100 mg viagra capsules. Therefore causes of erectile dysfunction in 50s buy discount viagra capsules online, during ureteroscopy erectile dysfunction under 35 order viagra capsules 100 mg amex, the tidal volume could be decreased to minimize renal excursions during respiration. Moreover, the physiologic ureteral contractions or peristalsis can be observed endoscopically. It is important to wait for the ureter to relax before pushing the ureteroscope to avoid mucosal trauma (Andonian et al, 2008b, 2010b). An extrarenal pelvis is usually larger and has longer major calyceal infundibula than an intrarenal pelvis. In the renal pelvis, the flexible ureteroscope first faces the ostia of the major calyces, which look like circular openings separated by carinae. Then the flexible ureteroscope enters a long tubular infundibulum that branches into the minor calyces. For a flexible ureteroscope to pass from the axis of the upper ureteral segment to the axis of the lower infundibulum, it should deflected 140 (104 to 175) degrees at the ureteroinfundibular angle (Bagley and Rittenberg, 1987). A circular muscle layer extends around the base of the papilla to help expel urine jets from papillary ducts. The renal papillae appear endoscopically as protruding discs surrounded by calyceal fornices, paler in color than the pink friable epithelium covering the papillae. Each papilla represents the apex of a renal pyramid, receiving the papillary ducts of Bellini that drain the pyramids. These ducts are minute openings that become more dilated and obvious with distal obstruction (Andonian et al, 2008a, 2010a). Relationship of increased renal cortical echogenicity with clinical and laboratory findings in pediatric renal disease. Martin, PhD Urine Transport Pathologic Processes Affecting Ureteral Function Effect of Age on Ureteral Function Effect of Pregnancy on Ureteral Function Effect of Drugs on the Ureter Development of the Ureter Electrical Activity Contractile Activity Mechanical Properties Role of the Nervous System in Ureteral Function The function of the ureter is to transport urine from the kidney to the bladder. Under normal conditions, ureteral peristalsis originates with electrical activity at pacemaker sites located in the proximal portion of the urinary collecting system (Bozler, 1942; Weiss et al, 1967; Constantinou, 1974; Gosling and Dixon, 1974; Tsuchida and Yamaguchi, 1977; Zhang and Lang, 1994; Lammers et al, 1996; Weiss et al, 2006; Hurtado et al, 2010). The electrical activity is then propagated distally and gives rise to the mechanical event of peristalsis, ureteral contraction, which propels the bolus of urine distally. Along with dense bodies dispersed in the cytoplasm, they serve as attachment devices for the actin. Around the periphery of the cell are numerous cavitary structures, some of which open to the outside of the cell and are referred to as caveolae. These caveolae contain a cytoskeletal protein, caveolin, and a variety of signal transduction molecules and receptors for growth factors and cytokines (William and Lisanti, 2004). The inner plasma membrane surrounds the entire cell, but the outer basement membrane is absent at areas of close cell-to-cell contact, referred to as intermediate junctions. Signals from the metanephric mesenchyme, stroma, and angioblasts induce the ureteral bud to arise from the mesonephric duct, invade the metanephric mesenchyme, and undergo branching. The cell is extremely small, approximately 250 to 400 µm in length and 5 to 7 µm in diameter. The nucleus, which is separated from the remainder of the cell by a nuclear membrane, is ellipsoid and contains a darkly staining body, the nucleolus, and the genetic material of the cell. Surrounding the nucleus is the cytoplasm or sarcoplasm, which contains the structures involved in cell function. Frequently in close relation to the nucleus, mitochondria in the cytoplasm perform many of the nutritive functions of the cell. Depending on the local calcium ion (Ca2+) concentration, they interact to produce contraction or relaxation. Any process that leads to a significant increase in the Ca2+ concentration in the region of the contractile proteins results in contraction; conversely, any process that leads to a significant decrease in the Ca2+ concentration in the region of the contractile proteins results in relaxation. Actin is dispersed throughout the sarcoplasm in hexagonal clumps and is interspersed with the less numerous clumps of more deeply staining myosin. Programmed cell death, or apoptosis, is involved in branching of the ureteric bud and subsequent nephrogenesis. Inhibitors of caspases, which are involved in the apoptotic signaling pathway, inhibit ureteral bud branching (Araki et al, 1999). During development, the ureteral lumen is obliterated, and then it recanalizes (Russo-Gil et al, 1975; Alcaraz et al, 1991). Calcineurin, a Ca2+-dependent serine/threonine phosphatase, also appears to be an essential signaling molecule in urinary tract development. Mutant mice in which calcineurin function is removed are noted to have reduced proliferation of smooth muscle and mesenchymal cells in the developing urinary tract with abnormal development of the renal pelvis and ureter with resultant defective pyeloureteral peristalsis (Chang et al, 2004). The ionic basis for electrical activity in ureteral smooth muscle has not been fully described; however, many of its properties resemble those in other excitable tissues. In the resting state, the K+ concentration on the inside of the cell is greater than that on the outside of the cell-that is, K+i is greater than K+o-and the membrane is preferentially permeable to K+. Although the low resting potential of ureteral cells may be explained in part by a relatively small resting K+ conductance (Imaizumi et al, 1989), it also may be a result of the contribution of other ions. In the resting state, the Na+ concentration on the outside of the cell membrane is greater than that on the inside- that is, Na+o is greater than Na+i. If the resting membrane were somewhat permeable to Na+, both the concentration and the electrical gradient would support an inward movement of Na+ across the cell membrane, with a resultant decrease in the electronegativity of the inner surface of the cell membrane. Na+-Ca2+ exchange also may play a role in Na+ extrusion, especially when the Na+ pump is inhibited (Aickin, 1987; Aickin et al, 1987; Lamont et al, 1998). Activation of Ca2+-activated Cl- channels (ClCa) also can decrease the membrane potential and therefore depolarizes the membrane (Verkman and Galietta, 2009). The electrical gradient that is formed tends to oppose the further movement of K+ outward across the cell membrane along its concentration gradient, and an equilibrium is reached. When a ureteral cell is stimulated, depolarization occurs, with the inside of the cell membrane becoming less negative than it was before stimulation. If a sufficient area of the cell membrane is depolarized rapidly enough to reach a critical level of transmembrane potential, referred to as the threshold potential, a regenerative depolarization, or action potential, is initiated. If a stimulus is very weak, as shown by arrow a, the transmembrane potential may remain unchanged. A slightly stronger, yet subthreshold, stimulus may result in an abortive displacement of the transmembrane potential, but not to such a degree that an action potential is generated (arrow b). If the stimulus is strong enough to decrease the transmembrane potential to the threshold potential, the cell becomes excited and produces an action potential (arrow c). The action potential, which is the primary event in the conduction of the peristaltic impulse, has the capability to act as the stimulus for excitation of adjacent quiescent cells and through a complicated chain of events gives rise to the ureteral contraction. A, Electrochemical changes that would occur if the membrane were solely permeable to potassium. Potassium would diffusefromtheinsideofthecell,whereitismoreconcentrated,to the outside of the cell, where it is less concentrated. As the positively charged Ca2+ ions move inward across the cell membrane, the inside of the membrane becomes less negative with respect to the outside and may even become positive at the peak of the action potential, a state referred to as overshoot. Na+ ions also may play a role in the upstroke of the ureteral action potential (Kobayashi, 1964, 1965; Muraki et al, 1991). The rate of rise of the upstroke of the ureteral action potential is relatively slow, 1. The slow rate of upstroke rise of the ureteral action potential accounts for the slow conduction velocity in the ureter. After reaching the peak of its action potential, the ureter maintains its potential for a period of time (plateau of the action potential) before the transmembrane potential returns to its resting level (repolarization) (Kuriyama et al, 1967). The plateau phase of the guinea pig action potential is superimposed with multiple oscillations, a phenomenon not observed in the rat, rabbit, or cat. There are species differences in the ionic currents involved in the formation of the action potential, with the Ca2+-activated chloride current being present in the rat but not in the guinea pig ureter. The inward Cl- current can be inhibited by niflumic acid and by Ba2+ (Smith et al, 2002). The oscillations on the plateau of the guinea pig action potential appear to depend on the repetitive activation of an inward Ca2+ current (Kuriyama and Tomita, 1970) and of a Ca2+-dependent outward K+ current (Imaizumi et al, 1989). Prolongation of the inward calcium current and the duration of the action potential correlates with an increased force of contraction (Burdyga and Wray, 1999b). The activation of a Ca2+-dependent K+ current that is involved in repolarization is mainly a result of Ca2+ release from the endoplasmic reticulum that is triggered by the influx of extracellular Ca2+ through voltage-dependent Ca2+ channels. Schematic representation of ionic currents in A, nonpacemaker (solid line) and B,pacemaker(dashed line)actionpotentials:0,upstrokeordepolarizationphase;2,plateau phase; 3, repolarization phase; and 4, resting potential of the nonpacemaker cell and spontaneous depolarization phase of the pacemaker cell. A spontaneous decrease in the transmembrane potential of pacemaker cells accounts for their spontaneous activity. The duration of the action potential in the cat ranges from 259 to 405 msec (Kobayashi and Irisawa, 1964). When excited by a suprathreshold stimulus, the membrane becomes less permeable to K+ and more permeable to Ca2+, which moves inward across the cell membrane and provides the ionic mechanism for the development of the upstroke of the action potential. After reaching the peak of its action potential, the membrane maintains a depolarized state-plateau of the action potential-for a period of time before the membrane potential of the activated cell returns to its resting level (repolarization). The plateau appears to be related to a persisting inward Ca2+ current and to an influx of Na+. Repolarization of the membrane is related to a renewed increase in permeability to K+. If the activity arises spontaneously, the cell is referred to as a pacemaker cell. Pacemaker cells differ from nonpacemaker cells in that their transmembrane resting potential is lower (less negative) than that of nonpacemaker cells (Lang and Zhang, 1996) and does not remain constant but rather undergoes a slow spontaneous depolarization. If the spontaneously changing membrane potential reaches the threshold potential, the upstroke of an action potential occurs. The ionic conduction underlying pacemaker activity in the upper urinary tract is caused by the opening and slow closure of voltageactivated L-type Ca2+ channels (Santicioli et al, 1995a). This is opposed by the opening and closure of voltage- and Ca2+-dependent K+ channels. Tetrodotoxin and blockers of the autonomic nervous system, both parasympathetic and sympathetic, have little effect on peristalsis, suggesting that autonomic neurotransmitters have little role in maintaining pyeloureteral motility (Lang et al, 2001, 2002b). Changes in the frequency of action potential development may result from a change in the level of the threshold potential, a change in the rate of slow spontaneous depolarization of the resting potential, or a change in the level of the resting potential. Gosling and Dixon (1971, 1974) provided morphologic evidence of specialized pacemaker tissue in the proximal portion of the urinary collecting system and described species differences. In species with a multicalyceal system, such as the pig, sheep, and human, the pacemaker cells are located near the pelvicalyceal border (Dixon and Gosling, 1973). These atypical smooth muscle cells that give rise to pacemaker activity, in contrast to typical smooth muscle cells, have less than 40% of their cellular area occupied by contractile elements and demonstrate sparse immunoreactivity for smooth muscle and actin (Klemm et al, 1999; Lang et al, 2001). These atypical smooth muscle spindleshaped cells are 90 to 230 µm in length, and their electrical activity consists of simple waveforms of alternating depolarizing and repolarizing phases that occur at a relatively rapid frequency of 8 to 15 per minute. In the guinea pig these atypical, presumably pacemaker, cells comprise more than 80% of the cells at the pelvicalyceal junction and about 15% of the cells in the proximal renal pelvis but are not present in the distal renal pelvis or ureter (Klemm et al, 1999). Electrical recordings correlate with histologic findings in that pacemaker potentials were not observed in the distal renal pelvis or ureter (Klemm et al, 1999). Driven action potentials that fire at lower frequency (three to five per minute) than pacemaker potentials are recorded from longer (150 to 400 µm) spindle-shaped typical smooth muscle cells. Identification of the cells underlying pacemaker activity in the guineapigupperurinarytract. Electrical recordings from these cells demonstrate action potentials with properties intermediate to pacemaker and driven action potentials. Intermediate action potentials in the guinea pig have a single spike, a plateau without the superimposed spikes seen in driven action potentials, and a rapid repolarization phase. Intermediate action potentials are noted in 11% to 17% of cells at the pelvicalyceal junction and the proximal and distal renal pelvis (Lang et al, 2002b). Bozler (1942), using small extracellular surface electrodes, demonstrated the characteristic slow spontaneous depolarization of pacemaker-type fibers in the proximal portion of the isolated ureter of a unicalyceal upper collecting system. In a multicalyceal kidney, Morita and associates (1981), using extracellular electrodes, recorded low-voltage potentials that appeared to be pacemaker potentials from the border of the pig minor calyces and the major calyx, with the contraction rhythm varying between each calyx. Multiple pacemakers fire simultaneously as coupled oscillators or individually as pacemaker activity shifts from one site to another along the renal pelvis of the unicalyceal kidney or the pelvicalyceal border of the multicalyceal pig and sheep kidney (Golenhofen and Hannappel, 1973; Constantinou et al, 1977; Constantinou and Yamaguchi, 1981; Lammers et al, 1996). Although the primary pacemaker for ureteral peristalsis is located in the proximal portion of the collecting system, other areas of the ureter may act as latent pacemakers. Under normal conditions, the latent pacemaker regions are dominated by activity arising at the primary pacemaker sites. When the latent pacemaker site is freed of its domination by the primary pacemaker, it, in turn, may act as a pacemaker. To demonstrate latent pacemaker sites, Shiratori and Kinoshita (1961) transected the in vivo dog ureter at various levels. Before transection, peristaltic activity arose proximally from the primary pacemaker. Latent pacemaker cells are present throughout the ureter (Imaizumi et al, 1989; Meini et al, 1995). Any process that results in a significant increase in Ca2+ in the region of the contractile proteins favors the development of a contraction; any process that results in a significant decrease in Ca2+ in the region of the contractile proteins favors relaxation. The transverse resistance of the membrane is higher than the longitudinal resistance of the extracellular or intracellular fluid; this allows current resulting from a stimulus to propagate along the length of the fibers. The spread of current is referred to as electrotonic spread (Hoffman and Cranefield, 1960).

The holmium laser is one of the safest erectile dysfunction drugs and nitroglycerin cheap 100mg viagra capsules with amex, most effective erectile dysfunction treatments diabetes cheap viagra capsules 100mg buy on-line, and most versatile intracorporeal lithotripters erectile dysfunction treatment nyc 100 mg viagra capsules for sale. Further advantages of the holmium laser include its production of significantly smaller fragments compared with other lithotrites impotence test 100 mg viagra capsules purchase. These small fragments are easily irrigated out of the collecting system erectile dysfunction testosterone injections cheap viagra capsules 100mg without a prescription, which reduces the need for extraction of the fragments with basket or grasping devices (Teichman et al, 1998a). However, the 365and 550-µm laser fibers will cause significantly more retropulsion than the 200-µm fibers (White et al, 1998). Of note, Kang and associates (2006) demonstrated that not just the laser fiber size, but also laser settings, such as the pulse duration, will affect stone retropulsion. The authors found that stone retropulsion could be significantly reduced by increasing the laser pulse duration. The holmium laser has several distinct operating advantages compared with the coumarin pulsed-dye laser. The required eye protection for the holmium laser does not compromise the ureteroscopic view of the stone or the fiber (Segura, 1999). In fact, the holmium laser properties are such that with use of energy levels applied for stone disease. The holmium laser is more compact than the coumarin laser, requires minimal maintenance, and is ready for use 1 minute after it is activated. The major disadvantage of the holmium laser is the initial high cost of the device and the cost of the laser fibers. However, the holmium laser has multiple soft tissue applications and can be used to treat patients with benign prostatic hyperplasia, strictures, and urothelial tumors. The most significant improvement in holmium laser lithotripsy will likely come from improved delivery fibers. At present, the smallest fiber in widespread use, the 200-µm fiber, impedes deflection of a flexible ureteroscope by up to 20 degrees. As smaller laser fibers, such as those of 150-µm diameter and smaller, are produced, it is likely that this effect on endoscope deflection will be further reduced. The fracture of a laser fiber inside an endoscope can result in a catastrophic failure of the scope, because when this occurs the fiberoptic bundles that transmit images and light are generally destroyed. The thulium fiber laser has emerged as a potential therapeutic alternative to the holmium laser, because it may hold several advantages over the holmium platform. Its laser fibers are smaller, which may permit improved endoscope deflection and irrigation flow (Blackmon et al, 2010). The technique of holmium laser lithotripsy is relatively straightforward and involves placement of the fiber on the stone surface before the laser is activated. After initiation of holmium laser lithotripsy, a short pause is often required because of the "snowstorm effect" created by the scattering of minute stone fragments, which can be cleared by endoscopic irrigation (Scarpa et al, Lithotripters Ballistic Lithotripsy. The initial movement of the projectile can be induced by a variety of stimuli, but once the projectile is in contact with another object the ballistic energy is transferred to the object. Flexible objects preserve the momentum of the energy, but inflexible objects, such as a stone, fragment on impact (a "jackhammer" effect). The metal projectile in the hand piece of the LithoClast is propelled by measured bursts of compressed air against the head of a metal probe at a frequency of 12 cycles per second. The probe tip is placed against the stone, and the LithoClast is activated by a foot pedal (Denstedt et al, 1992). Rane and associates (2008) first reported on a novel, handheld ballistic lithotripter, the StoneBreaker (Cook Medical, Bloomington, Probe (1-3. This portable device uses a small cylinder-based air supply, rather than hospital air, simplifying its ergonomic profile. Wang and associates (2012) investigated an alternative hand-held device, the Swiss LithoBreaker (Electro Medical Systems, Nyon, Switzerland), an electrokinetic device. In their in vitro effort, the authors found that although it was efficient in a ureteroscopic model, it performed poorly in a percutaneous model (Wang et al, 2012). The ballistic lithotrites provide an effective means for stone fragmentation in the entire urinary tract, with a wide margin of safety. As well, a significant decrease in the maximum tip displacement and velocity of the LithoClast 0. Grocela and Dretler (1997) also reported that for the current ballistic devices, bowing of the probe during lithotripsy results in significant power loss. In contrast to ureteral stones, kidney stones are easily "pinned down" against the urothelium during ballistic lithotripsy, allowing a rapid and more efficient fragmentation method than ultrasonic lithotripsy. Once the bulk of the calculus is fragmented, lithotripsy can be completed with the ultrasonic lithotripter, which can also aspirate minute stone fragments (Denstedt, 1993; Teh et al, 1998; Yavascaoglu et al, 1999). In an animal model, despite 6 minutes of activation in direct contact with the ureteral wall, a ballistic lithotripter was unable to cause perforation (Santa-Cruz et al, 1998). Furthermore, because no heat is produced during lithotripsy, the risk for thermal injury to the urothelium is eliminated. One of the advantages of ballistic lithotrites is their relatively low cost and low maintenance. Disadvantages of ballistic devices include the rigid nature of the technology, which requires ureteroscopes or nephroscopes with straight working channels. In addition, ballistic lithotripsy is associated with a relatively high rate of stone retropulsion, reported in 2% to 17% of ureteral stone treatments. Often, failure to fragment a stone is related to an inability to trap a ureteral stone in a capacious ureter (Denstedt et al, 1992). The migration rate depends on the initial stone location; there is a higher chance of stone migration for proximal ureteral stones compared with distal ureteral stones (Knispel et al, 1998). Limited data are available on the beneficial effects of suction devices, such as the LithoVac (Boston Scientific), in limiting stone migration. Overall stone-free rate at 3 months was 95%, and the suction device reportedly facilitated lithotripsy by preventing stone migration and maintaining a clear endoscopic view. Fragmenting a stone into pieces smaller than 4 mm with a ballistic lithotripter can be challenging, especially a hard stone in a dilated ureter. Fragments larger than 4 mm are associated with a higher rate of repeated ureteroscopy and therefore should be removed with baskets or stone graspers during the initial procedure (Keeley et al, 1999). Like other lithotrites, the ballistic lithotripter should be activated only when there is a clear view of the stone and the probe position can be identified. Fixation of the stone is rarely difficult in the kidney or the bladder but may be a problem in the ureter. Fixation of ureteral stones with a basket or proximal placement of a ureteral occlusion device is sometimes necessary (Ursiny and Eisner, 2013). The goal of ballistic lithotripsy in the ureter is to generate fragments that are small enough to permit spontaneous passage (<2 mm). However, more often, larger fragments have to be removed with a basket or grasping device. The relatively atraumatic nature of ballistic lithotripsy may allow the avoidance of stent placement after ureteroscopy. Tan and colleagues (1998) reported the use of a stent in only 9 of 68 patients undergoing ballistic lithotripsy. In this series, difficult ureteral access and severe edema and trauma at the site of stone impaction were indications for stent placement. Mulvaney (1953) first reported the use of ultrasound vibrations to break renal calculi in 1953. The ultrasound probe works by applying electrical energy to excite a piezoceramic plate in the ultrasound transducer. The plate resonates at a specific frequency and generates ultrasonic waves at a frequency of 23,000 to 25,000 Hz. At operating frequencies there is no audible sound, although 98 dB of ultrasonic inaudible noise levels has been measured (Segura and LeRoy, 1984). Ultrasound energy is transformed into longitudinal and transverse vibrations of the hollow steel probe, which then transmits the energy to the calculus. The probe tip causes the stone to resonate at high frequency and to break; but when the probe is placed on compliant tissue, such as urothelium, damage is minimal because the tissue does not resonate with the vibrational energy (Grocela and Dretler, 1997). Although some heat may develop at the end of the probe during lithotripsy, with an irrigation rate of 30 mL/min the temperature increase at the tip of the probe can be reduced to a maximum of 1. As with other intracorporeal lithotripsy devices the goal of treatment is either to fragment the stone completely or to generate fragments that are small enough to be extracted or passed spontaneously. In addition, the flow of fluid through the hollow probe serves to cool the instrument. Heating of the ultrasound transducer should alert the surgeon to possible occlusion in the probe lumen, an occurrence more commonly encountered with small-diameter probes that are used in the ureter. Although many manufacturers provide an integrated power and suction foot switch for the ultrasonic unit, wall suction with intermittent clamping of the suction tubing by an assistant is a simple and inexpensive alternative. In general, suction is applied only when the ultrasonic lithotripter is activated, and suction pressures in the range of 60 to 80 cm H2O are sufficient to maintain adequate flow of irrigant during lithotripsy. Higher suction pressures tend to draw air bubbles into the system, impeding vision. Bending the probe results in energy loss at the convexity of the bend, with the energy being transformed to heat (Marberger, 1983). Although the chemical composition of the stone influences the time required for complete disintegration (cystine, calcium oxalate monohydrate, and uric acid being the most resistant to fragmentation), the size, density, and surface structure of the calculus appear to be more important. Smooth-surfaced large stones may be more difficult to fragment (Marberger, 1983; Segura and LeRoy, 1984). The major advantage of ultrasonic lithotripsy is the efficient combination of stone fragmentation and simultaneous fragment removal. Fragments smaller than 2 mm are aspirated through the hollow lithotrite along with the irrigation fluid. The efficiency of this technique coupled with the minimal risk for serious tissue damage has made this technology popular. However, the rigid nature of ultrasonic probes and their small diameter limit the appeal of this technology in treatment of ureteral stones. Furthermore, a relatively large 5-Fr working channel is needed to accommodate the 4. However, success rates between 69% and 100% have been reported (Denstedt, 1996; Gur et al, 2004). The technology may be particularly useful for patients with large ureteral stones as well as for those with steinstrasse because removal of stone debris is facilitated. Excellent results also have been reported for distal ureteral stones easily accessible to the rigid ureteroscope (Grocela and Dretler, 1997; Segura, 1999). However, in a later report, Murthy and associates (1997) compared a group of 25 patients treated by a rigid ureteroscope and the 3-Fr ultrasonic solid probe with a group of 122 patients treated by the LithoClast ballistic device, and the overall success rate was significantly higher for the LithoClast group than for the ultrasonic group (97. The application of gentle pressure to the stone enhances fragmentation, but the temptation to push too hard should be avoided because calculi can easily be pushed through the urothelium. The risk for perforation increases with smaller or more ruggedly surfaced stones because the force applied to the stone is transferred to a smaller surface area of the urothelium. The risk for perforation is particularly high in the thin-walled renal pelvis or ureter rather than in a calyx that is backed by renal parenchyma. When ureteral stones are treated the ureter may need to be dilated to allow passage of the offset rigid ureteroscope. The ultrasonic probe is passed through the working channel and placed directly on the stone. If necessary, the stone can be engaged in a Combination Ballistic and Ultrasonic Devices Several manufacturers have introduced combined ultrasonic and pneumatic devices that aim to combine the superior fragmentation ability of the pneumatic component with the ability of the ultrasonic modality to simultaneously evacuate stone fragments. The first combination device brought to the clinical market was the LithoClast Ultra, which relied on a combination hand piece (actually, two separate hand pieces connected together) to join the ultrasonic and pneumatic components. The first portion of the combination hand piece was a traditionally designed pneumatic handle, with a smaller diameter solid probe. The ultrasonic handle, driven by a standard piezoelectric mechanism, was modified to allow the coaxial insertion of the pneumatic probe. Each modality can be activated separately or in unison; when operated in unison, the ballistic fragmentation of the stone is accomplished with the pneumatic component and the ultrasonic component then removes the resulting debris. Given the varied types of rigid intracorporeal devices (standalone ballistic and ultrasonic as well as combination ballistic and ultrasonic), a rigorous and impartial evaluation of intracorporeal lithotripters is a subject of importance to urologists. Therefore a number of investigators have devised testing methods to compare intracorporeal lithotrites. Liatsikos and associates (2001) first reported an in vitro testing system designed to measure the efficiency of ultrasonic lithotrites in which stone phantoms were fragmented in a nephroscope-guided manner. The inherent weakness in this study design was that stone fragmentation was directed by hand, which could introduce significant operator bias. Haupt and Haupt (2003) subsequently reported an in vitro system that relied on an elaborate weight and fulcrum to bring a stone phantom into contact with the probe tip at a constant force. Although operator bias was no longer present, this system was complex and cumbersome, making replication challenging. Kuo and associates (2003b) have presented a novel and simple hands-free testing system in which the ultrasonic hand pieces were secured upright and the stone phantom placed into contact with the probe by a weight mechanism. This design system was first used to test the efficiency of pure ultrasonic lithotrites and measured the time it took for the probe to penetrate the stone phantom. After the introduction of the combination ultrasonic and pneumatic devices, the same testing apparatus previously used by Kuo and associates (2004) to evaluate the ultrasonic devices was used to evaluate the LithoClast Ultra. Because of the wide variety of ultrasonic power and pneumatic frequency settings available, the testing apparatus was used to assess the efficiency of various setting combinations. The end point was stone penetration time, and the fastest stone penetration times were achieved at settings of 100% ultrasonic power and 12-Hz pneumatic frequency.

order viagra capsules amex

viagra capsules 100 mg purchase with mastercard

Costs of an acute stone episode included an emergency department visit impotence jelly discount viagra capsules 100 mg with mastercard, associated radiographic imaging to confirm diagnosis of a symptomatic stone erectile dysfunction doctors in charleston sc cheap viagra capsules express, and outpatient treatment of upper urinary tract stones that did not pass spontaneously erectile dysfunction causes wiki purchase viagra capsules australia. Not surprisingly impotence yoga postures buy genuine viagra capsules online, the costs of medical prophylaxis and managing an acute stone episode varied significantly from country to country erectile dysfunction treatment in jamshedpur generic viagra capsules 100 mg. The stone frequency at which costs of these management options became equivalent ranged from 0. This study concluded that medical management of a first stone episode is not cost-effective and that individual decisions should be determined by local costs. Researchers at the University of Texas, Southwestern Medical Center have created a decision tree model to evaluate the costeffectiveness and stone recurrence rates of common management strategies in stone formers (Lotan et al, 2004). They evaluated four common medical strategies: dietary measures alone (conservative), empirical drug treatment, or directed drug therapy based on simple or comprehensive metabolic evaluation. The model made reasonable assumptions regarding costs for evaluation, medications, emergency treatment, and surgery for stone recurrence. A review of the literature guided estimations of stone recurrence and risk reduction from various medical therapies. They found that firsttime stone formers were best treated with a conservative approach because it was the least costly and it yielded a stone formation rate of 0. For recurrent stone formers, conservative treatment was less costly than drug treatments but it was associated with a higher stone recurrence rate (0. Directed medical therapies were more costly than conservative treatment ($885 to $1187 vs. The authors went on to compare the expense of the simple medical evaluation and associated management as described earlier in this chapter and noted it to be more costly than empirical treatment but also more effective. Importantly, a complete evaluation with attendant treatment offered no advantage in cost or efficacy over empirical treatment or modified simple metabolic evaluation and management. The authors also recommended that first-time stone formers be treated with conservative therapy because it is both cost-effective and efficacious. In contrast, however, recurrent stone formers should be treated medically after a simplified evaluation, because of the high recurrence rate of stone formation. Despite the recommendation for recurrent stone formers to undergo a simplified evaluation, Milose and colleagues found that in 2006 only 7. The details regarding the physiology and pathophysiology of these distinct entities are included in Chapter 51. These categories are listed in Table 52-4, along with the relative frequency of their occurrence as noted by Pak and colleagues at a dedicated Stone Clinic in an academic medical center (Levy et al, 1995). An argument can be made that these relative incidences may not be representative of the general population for two reasons. First, referral to an academic center may imply a more serious version of stone disease and may therefore represent a selection bias. Second, recognizing that there are at least some regional variations of stone incidence (Harvey et al, 1990), this particular patient population may be distinctly different from those in a different region of the United States or other regions of the world. The classification of nephrolithiasis recognizes three broad categories of hypercalciuria. Absorptive hypercalciuria involves an increase in the amount of calcium absorbed by the intestinal tract. Therefore these subjects will demonstrate an increased urinary excretion of calcium on both the fasting and the loading specimens. Renal hypercalciuria (also known as renal leak hypercalciuria) is thought to be due to a wasting of calcium by the functioning nephron. As a result of constant loss of calcium from the distal tubules, these patients will demonstrate hypercalciuria during all phases of fasting, loading, or restricting of dietary calcium. Patients with resorptive hypercalciuria suffer from an overproduction of parathyroid hormone from either one dominant adenoma or diffuse hyperplasia of all four glands. The hallmark of this disorder is the persistence of increased urinary calcium during all parts of the dietary calcium manipulations. In addition, these patients frequently demonstrate hypercalcemia and elevations of the parathyroid hormone. Although this diagnosis is not as "clean" as possible, it represents a more pragmatic approach to hypercalciuria, because the treatment for absorptive and renal hypercalciuria is often the same (as outlined later in this chapter). Table 52-5 summarizes the laboratory parameters that help delineate the various types of hypercalciuria. Hyperuricosuric Calcium Oxalate Nephrolithiasis Patients with hyperuricosuria may be prone to the formation of calcium oxalate calculi through the process of heterogeneous nucleation (also referred to as epitaxy) (Coe and Kavalach, 1974; Pak and Arnold, 1975; Coe, 1980). These patients give a history of calcium oxalate nephrolithiasis and may have a history of hyperuricemia with symptomatic gout. During metabolic evaluation, these patients will demonstrate hyperuricosuria (>800 mg/day). In these instances the patients can be treated with a 2-week course of a thiazide diuretic, such as chlorthalidone 25 mg daily. Idiopathic hypercalciuria can be found in both normal people and stone formers (Coe et al, 1979). These patients may demonstrate elevated amounts of urine calcium in all phases of the dietary calcium manipulation, but will not demonstrate serum abnormalities. On a cautionary note, this term does not always enjoy a strict definition and is sometimes sub- Hyperoxaluria (>40 mg/day) Enteric Hyperoxaluria. This entity is often one of the most striking findings during a metabolic evaluation because it involves multiple factors, all caused as a result of chronic diarrhea with its attendant dehydration and bicarbonate losses (Worcester 2002). The main hallmark is, of course, hyperoxaluria with values that can be quite high. As a result of intestinal fluid loss, patients will often exhibit low urine volumes. The bicarbonate loss (and the consumption of citrate as an acid/base buffer) also can cause a low urine pH and hypocitraturia (Rudman et al, 1980). Urine calcium excretion is often low because of the saponification of oral calcium with poorly absorbed fats in the intestinal tract. Primary hyperoxaluria is an extremely rare disorder caused by an inborn error of metabolism. Type 2 is a less common variant thought secondary to a defect in D-glycerate dehydrogenase, which has both glyoxylate and hydroxypyruvate reductase. Death often occurs before age 20 in untreated patients (Williams and Smith, 1968; Leumann and Hoppe 1999). Metabolic evaluation will reveal high urine oxalate excretion and high serum levels of this molecule. The importance of dietary oxalate and the possibility of an inheritable sensitivity to oral oxalate loads are debated and are discussed in Chapter 51. It appears increasingly evident that a deficiency of a bacterium found within intestinal flora (Oxalobacter formigenes) is a factor in the formation of calcium oxalate calculi (Allison et al, 1986; Sidhu et al, 1999; Troxel et al, 2003; Siener et al, 2013). In some patients, the cause of Oxalobacter deficiency may be iatrogenic because it is sensitive to a number of commonly prescribed antibiotics, including ciprofloxacin and levofloxacin (Lange et al, 2012). Regardless of the underlying cause, some patients without primary hyperoxaluria or without a history of bowel disorders will demonstrate an elevation of oxalate in 24-hour urine collection. Although this molecule is ubiquitous and cannot be avoided, certain foods can deliver substantial amounts of oxalate in one serving. Box 52-3 presents an abbreviated list of foodstuff that are particularly high in oxalate (Assimos and Holmes, 2000; Holmes and Assimos, 2004). A recent pilot study suggests that compliance with dietary modifications to reduce oxalate intake can be improved with an interactive Internet program (Lange et al, 2013). Infants generally present with vomiting or diarrhea, failure to thrive, and growth retardation; children often present with metabolic bone disease and renal stones; and adults frequently present with symptoms attributable to nephrolithiasis and nephrocalcinosis. Those patients with onset at an early age or with severe forms of the disorder may develop nephrocalcinosis and eventual renal insufficiency. Some patients will have an incomplete variant of the disease with less marked hypocitraturia and a more normal urine pH level. Hypocitraturic Calcium Nephrolithiasis (<550 mg, Female; <450 mg, Male) There is some controversy regarding the definition of normal urinary citrate excretion. Women tend to have higher urinary citrate measurements than men, particularly before menopause (Pak, 1990). Despite noting gender differences, Pak (1990) and colleagues define normal urine citrate as greater than 320 mg for both genders. In some of the earlier studies from Dallas, hypocitraturia was found in up to 50% of all patients evaluated, frequently in association with other abnormalities (Nicar et al, 1983). Parks and Coe (1986) also noted the importance of urinary citrate for the prevention of calcareous stones and have set the limits of normal at higher values, with men being more than 450 mg and women at more than 550 mg daily. Nevertheless, hypocitraturia is considered one of the more common metabolic diagnoses, probably second only to hypercalciuria. Regardless of the actual cause, the laboratory hallmark of this disease is a low urine citrate (hypocitraturia) with an inappropriately high urine pH (Wang and Preminger, 2011). Often, the measured 24-hour urine citrate will be quite diminished, with values less than 100 mg/day. Excessive dependence on laxatives may induce a pattern similar to chronic diarrheal states (Dick et al, 1990; Soble et al, 1999). The importance of this disorder has been questioned, however, with the suggestion that the stone-risk association of hypomagnesuria may actually be due to its effect on urinary citrate (Schwartz et al, 2001). Because there are no known inhibitors of uric acid crystallization, undissociated uric acid will precipitate when the urine becomes supersaturated. It follows, then, that patients with gouty diathesis and uric acid calculi tend to have lower urine pH than normal subjects (Gutman and Yu 1968). Up to 20% of patients with gout will develop uric acid calculi, prompting examination of serum for hyperuricemia. Often, 24-hour urine collections can underestimate the total amount of uric acid if the specimen pH drops lower than 5. In this scenario, the uric acid forms precipitates and settles to the bottom of the collection container. In contrast, those with gouty diathesis have a low fractional excretion of urate (that contributes to hyperuricemia) and low urinary pH (that leads to increased amount of undissociated uric acid) (Khatchadourian et al, 1995; Pak et al, 2003c). A dietary history should be obtained from all patients with uric acid calculi, because they may have a tendency to purine gluttony (high intake of animal protein). An astute clinician will at least give a brief consideration to the possibility of a neoplastic or myeloproliferative disorder. Patients with diabetes mellitus also may form uric acid calculi as a result of disorders in ammonium handling with subsequent low urine pH (Pak et al, 2003c; Eisner et al, 2010b). These stones frequently have an orange appearance, especially when viewed endoscopically. Uric acid­stone formers can have a propensity to produce large volumes of very small calculi that may cause obstruction as they pass down the ureter. Incomplete variants can be diagnosed with the use of an ammonium chloride loading challenge. Subsequently, hourly measurements of urinary pH and bi-hourly measurements of serum pH or bicarbonate are taken over 4 to 6 hours (Pohlman et al, 1984). The laboratory findings in a patient with a chronic diarrheal disorder are similar to those in patients with enteric hyperoxaluria. However, these patients do not tend to suffer from the bowel inflammation and subsequent heightened permeability to oxalate. Therefore urinary oxalate may be mildly elevated, but usually not to the extent as found in patients with bowel resection or inflammatory disorders. These patients likely will demonstrate moderate decreases in urinary citrate excretion with associated low urine volumes (Fegan et al, 1992; Caudarella et al, 1993; Worcester, 2002; Parks et al, 2003b). This defect is presumably secondary to the hypokalemia and resultant intracellular acidosis that may develop after prolonged therapy with thiazides (Pak et al, 1985b). Because thiazides are still widely used as a diuretic and for the management of hypertension, some patients may present with a stone episode after prolonged therapy with this medication. Stone patients who are treated with thiazides for the control of hypercalciuria should be screened for hypocitraturia (Pak et al, 1985b). Patients with idiopathic hypocitraturia include all those with 24-hour urine citrate less than 550 mg (males) or 450 mg (female) in the absence of any of the previously noted disease states. Hypomagnesuric Calcium Nephrolithiasis (<80 mg) Hypomagnesuric calcium nephrolithiasis is characterized by low urinary magnesium, hypocitraturia, and low urine volume. It is frequently associated with chronic thiazide therapy (Ljunghall et al, 1981; Preminger et al, 1989). The authors noted that hypercalciuria, hyperuricosuria, and hypocitraturia frequently accompany cystinuria and speculated that these conditions might be renal in origin, rather than a result of dietary or environmental aberrations. They further concluded that these unrelated anomalies may contribute to the formation of calcium and uric acid stones, which sometimes complicate cystine nephrolithiasis. A InfectionCalculi(Struvite) Struvite calculi form in the presence of alkaline urine (pH > 7. The ammonia is thought to be produced by the splitting of urea by colonization with bacteria that produce urease. Many bacterial organisms are able to produce this enzyme (Table 52-6), the most notorious of which is Proteus mirabilis. Although Escherichia coli is not able to spilt urea, it may be associated with struvite calculi in up to 13% of infections (perhaps through a metachronous infection). Patients with these calculi may present with the symptoms of acute pyelonephritis, including fevers, chills, flank pain, dysuria, frequency, urgency, and malodorous, cloudy urine. Some patients may exhibit more chronic symptoms of malaise, fatigue, loss of appetite, and generalized weakness. Rarely, infections and obstruction have been long-standing enough to produce xanthogranulomatous pyelonephritis, which may cause the failure of an entire kidney or may just affect a portion. Women are more often affected with struvite calculi than men, likely because of an increased susceptibility to urinary tract colonization. Struvite calculi can be quite large and often fill multiple calyces or even the entire collecting system.

purchase cheapest viagra capsules and viagra capsules

cheap viagra capsules 100mg buy line

These protocols should help minimize costs erectile dysfunction treatment austin tx 100 mg viagra capsules order with mastercard, radiographic exposure impotence in men best buy for viagra capsules, and patient inconvenience while still allowing for detection of most clinically relevant recurrences (Donat et al erectile dysfunction pills in india purchase viagra capsules 100 mg without prescription, 2013) xylitol erectile dysfunction discount viagra capsules 100 mg with mastercard. The development of proteinuria correlated directly with the length of follow-up and inversely with the amount of remaining renal tissue how to fix erectile dysfunction causes order viagra capsules on line. Renal biopsy revealed focal segmental glomerulosclerosis in several patients with severe proteinuria. These findings mirror those observed in experimental animal models of partial renal ablation (Brenner, Chapter57 MalignantRenalTumors 1349 1983). Because proteinuria is the initial manifestation of this phenomenon, a 24-hour urinary protein measurement should be obtained yearly in patients with a solitary remnant kidney to screen for hyperfiltration nephropathy. Efforts to prevent or to ameliorate the damaging effects of renal hyperfiltration have focused on dietary and pharmacologic interventions, primarily the use of angiotensin-converting enzyme inhibitors combined with a low-protein diet (Goldfarb, 1995; Novick and Schreiber, 1995). Both can be administered percutaneously or through laparoscopic exposure and thus offer the potential for reduced morbidity and more rapid recovery (Johnson et al, 2004; Sterrett et al, 2008). Another concern has been the lack of accurate histologic and pathologic staging associated with these modalities, because the treated lesion is left in situ. Radiographic scanning is not recommended with pathologic confirmation of benign disease at or before treatment and post-treatment radiographic confirmation of treatment success and no evidence of treatment-related complications. New enhancement, a progressive increase in size of an ablated neoplasm with or without contrast enhancement, new nodularity in or around the treated zone, failure of the treated lesion to regress over time, or satellite or port site lesions should prompt a repeat lesion biopsy. Observation, repeat treatment, and surgical intervention should be discussed for recurrence. Finally, tumor size is also an important factor in patient selection because the current technology does not allow for reliable treatment of lesions larger than 4. Established prerequisites for successful cryosurgery include rapid freezing, gradual thawing, and a repetition of the freeze-thaw cycle. The mechanism underlying tissue cryodestruction is thought to involve immediate membrane and cellular damage followed by microcirculatory failure (Stein and Kaouk, 2007). Intracellular ice irreversibly disrupts cell organelles and the cell membrane, a lethal event. Delayed microcirculatory failure occurs during the slow thaw phase of the freeze-thaw cycle, leading to circulation arrest and cellular anoxia. Cells that survive the initial cryogenic assault are destroyed by this secondary insult of ischemia. Repetition of the rapid freeze­slow thaw cycle potentiates the damage (Hinshaw and Lee, 2004). Further work defined treatment parameters required to bring this treatment into the clinical domain. Chosy and colleagues (1996) demonstrated that complete and reliable tissue necrosis could be consistently achieved only at temperatures of -19. Campbell and coworkers (1998) confirmed that the target lethal temperature of -20°C was achieved at a distance of 3. Thus, to ensure complete cell kill, the iceball must extend well beyond the visible margins of the targeted tumor. In practice, we routinely extend the iceball approximately 1 cm beyond the edge of the tumor, as determined by real-time imaging (Gill et al, 1998). The availability of sophisticated and reliable ultrasonography and the introduction of finer cryoprobes that allow more accurate and less traumatic probe placement have contributed to even greater interest in visceral cryosurgery (Sterrett et al, 2008). Clinical experience and follow-up of patients after renal cryoablative therapy suggests successful local control in about 90% of patients, although many studies provide limited, and often incomplete, follow-up (Gill et al, 2005; Stein and Kaouk, 2007; Campbell and Palese, 2011; Klatte et al, 2011; Guillotreau et al, 2012). In general, central or nodular enhancement within the tumor bed on extended follow-up has been considered diagnostic of local recurrence, and the clinical experience with cryoablation has thus far supported this (Bolte et al, 2006; Weight et al, 2008). However, only a minority of studies have incorporated routine post-therapy biopsies to provide histologic confirmation of oncologic status (Gill et al, 2000; Weight et al, 2008). Other findings that suggest local recurrence include a progressive increase in size of an ablated neoplasm, new nodularity in or around the treated zone, failure of the treated lesion to regress over time, or satellite or port site lesions (Donat et al, 2013). If these features are found, biopsy and possible retreatment should be considered. More mature data are now available in a limited number of studies, supporting encouraging outcomes for smaller tumors, particularly those less than 3. Based on the definitions adopted for this guidelines process, thermal ablation should be restricted primarily to low-risk patients. For instance, in the series from Aron and colleagues (2010), the local recurrence rate at 5 years was 9%, and in the series from Lusch and colleagues (2013) it was approximately 8%. This can be contrasted with 5-year local recurrence rates of about 1% to 2% for surgical excision for analogous small renal masses (Campbell et al, 2009). Most local recurrences can be salvaged with repeat ablation, although some patients with progressive disease eventually require conventional surgery. Complications associated with cryoablation can include renal fracture, hemorrhage, adjacent organ injury, ileus, and wound infection, although major morbidity is decidedly uncommon (Sidana et al, 2010; Tsivian et al, 2010). These effects are observed at tissue temperatures above 41°C but increase directly with increasing temperature and duration of treatment (Sterrett et al, 2008). Temperatures in excess of 100°C are typically obtained at the tips of the probes, and thermosensors can be used to monitor progress during active treatment. Temperature dissipates at points more distant from the probe tip, and multiple probes or tynes are typically required to achieve adequate heating of the entire region of interest (Murphy and Gill, 2001). Rather, treatment is typically based on empirical results from previous probe alignments, supplemented by data from thermoprobes, and this allows a fairly predictable target zone of up to 4. Maximal tumor size that can be reliably treated would of necessity be smaller than this, given the need to extend the treatment zone beyond all edges of the tumor. Loss of enhancement on cross-sectional imaging within the lesion has generally been accepted as an indicator of success, although this has been challenged. Using strict criteria, local control was achieved in 91% of patients in this series; however, many of the patients with local recurrence were potentially salvaged with repeat ablation or surgical excision, and overall cancer-specific survival remained high. However, at present cell kill with these modalities is not sufficiently reliable and they are best considered developmental (Castle et al, 2011). During the period of observation these tumors grew at slow and variable rates of up to 1. Significantly, none of the patients developed metastasis during the period of surveillance. Subsequent series from several institutions have confirmed that many small renal masses will grow relatively slowly (median growth rate 0. However, a critical review of this literature is required to recognize the potential limitations of these studies (Campbell et al, 2009). A substantial proportion (20% or more) of these tumors may have been benign-biopsy was only performed in a minority of patients in these series. In addition, follow-up in most series is limited to 2 to 3 years, and in some cases the growth rate was calculated backward by obtaining old films for which the lesion of interest was either previously missed or dismissed, introducing a possible ascertainment bias (Jewett and Zuniga, 2008; Crispen et al, 2012). Finally, in most of these series there is a subpopulation of patients with rapidly growing tumors that appear to have more aggressive characteristics. For instance, in the series from Volpe and colleagues (2004), 25% of the masses doubled in volume in 12 months and 22% reached a diameter of 4 cm, triggering surgical intervention. Similarly, Sowery and Siemens (2004) reported 9 tumors with mean growth rate of 1. Even if these lesions are smaller than 3 cm, the current data indicate that most will grow and eventually reach a size at which metastasis becomes a possibility. Unfortunately, growth rates on observation do not allow for reliable differentiation of benign versus malignant histology (Siu et al, 2007; Crispen et al, 2008b; Kawaguchi et al, 2011). This process included a systematic meta-analysis of the literature, and the final document was vetted through an extensive peer review process. As expected, the database for open surgical techniques was most substantial and mature (Table 57-16). There were almost no comparative studies; the overwhelming majority were retrospective and primarily observational. The analysis revealed a small number of statistically significant comparisons of consequence for which confounding factors were unlikely to account for differences. A second significant result related to local recurrence, which was defined as any persistent or recurrent disease present in the treated kidney or ipsilateral renal fossa after initial treatment. This definition was adopted from standardized terminology developed by the International Working Group on Image-guided Tumor Ablation (Goldberg et al, 2005; Campbell et al, 2009). This was also judged to be a valid finding, because these modalities were used to treat relatively small tumors and had short follow-up durations. In reality, it has been estimated that, when confounding factors such as length of follow-up are Abdominal imaging Chest imaging *Please also refer to Table 57-12 for general considerations related to surveillance. Many such recurrences can be salvaged with repeat ablation, but when this is not possible, surgical salvage can be challenging (Kunkle et al, 2008; Nguyen et al, 2008b; Kowalczyk et al, 2009). Analyses of other survival end points, such as metastasisfree, cancer-specific, and overall survival, indicated that all such survival rates were relatively high across treatments, reflecting the limited biologic aggressiveness of most clinical T1 renal tumors. Given strong selection biases and highly variable follow-up differences across treatments, comparisons related to these outcomes were not informative (Campbell et al, 2009). Index patient 1, a healthy patient with a clinical T1a renal mass, is the most commonly encountered scenario. One of the main concepts that is emphasized by this guideline document relates to the status of nephron-sparing approaches as an overriding principle for the management of small renal masses, presuming that adequate oncologic control can be achieved (Campbell et al, 2009). Given the complexity of counseling with such divergent options for management, the panel believed strongly that a urologist should be involved in this process. The ongoing controversies about the management of larger renal masses in the presence of a normal contralateral kidney, and the need for better quality data, namely prospective, randomized trials, in this domain were reviewed previously. The panel also strongly advocated research priority for renal mass biopsy with molecular profiling to improve the estimation of tumor aggressiveness and facilitate more rational patient selection in this field. Although these are generally low-stage tumors, they are capable of progression to metastasis and represent a frequent cause of death in patients with von Hippel-Lindau disease. Standard: A guideline statement is a standard if: (1) the health outcomes of the alternative interventions are sufficiently well known to permit meaningful decisions, and (2) there is virtual unanimity about which intervention is preferred. Recommendation: A guideline statement is a recommendation if: (1) the health outcomes of the alternative interventions are sufficiently well known to permit meaningful decisions, and (2) an appreciable but not unanimous majority agrees on which intervention is preferred. Option: A guideline statement is an option if: (1) the health outcomes of the interventions are not sufficiently well known to permit meaningful decisions, or (2) preferences are unknown or equivocal. Algorithm for the evaluation, counseling, and management of the patient with a clinical T1 renal mass. The general philosophy has been to pursue nephron-sparing strategies whenever possible, given the multifocal nature of the disease, even for centrally located tumors (Grubb et al, 2005; Shuch et al, 2012b; Linehan and Ricketts, 2013). The 5-year and 10-year cancer-specific survival rates for all patients were 95% and 77%, respectively. Duffey and colleagues (2004) at the National Cancer Institute have defined a 3-cm threshold for intervention in patients with von Hippel-Lindau disease. In their series, a total of 108 patients with von Hippel-Lindau disease and solid renal tumors smaller than 3 cm were observed and none developed metastatic disease during mean follow-up of 58 months. A 3-cm cut point has thus been proposed to reduce the number of surgical interventions, to optimize renal function, and to minimize the risk of metastatic disease. Targeted agents are now being investigated in an effort to slow disease progression in patients with this syndrome (Grubb et al, 2005; Shuch et al, 2012b). When removal of all renal tissue is necessary for oncologic reasons, renal transplantation can provide satisfactory replacement therapy for end-stage renal disease and appears to be safe despite the tumor diathesis (Goldfarb et al, 1997). B,Histopathologic section of one of the renal cysts shows lining of clear cells representing incipient carcinoma. Administration of gadolinium during the study often allows tumor thrombus to be differentiated from bland thrombus, because the latter does not demonstrate enhancement. The importance of high-quality preoperative imaging cannot be overemphasized, and this imaging should be obtained as close as possible to the date of surgery because progression of the tumor thrombus may mandate important changes in intraoperative management (Blute et al, 2004b; Wotkowicz et al, 2008). Although inferior venacavography remains an accurate diagnostic study, this invasive technique is generally unnecessary in the modern imaging era. In patients with extensive supradiaphragmatic vena caval thrombi, when adjunctive cardiopulmonary bypass with deep hypothermic circulatory arrest is considered, coronary angiography should also be performed preoperatively (Novick et al, 1990). If significant obstructing coronary lesions are found, these can be repaired simultaneously during cardiopulmonary bypass. In general, level I thrombi are isolated by a Satinsky clamp and are thus readily addressed. The renal ostium is then opened and the thrombus is removed, all in a bloodless field. When tumor thrombus invades the wall of the vena cava, aggressive resection of the involved cava and attainment of negative surgical margins are required to minimize the risk of recurrence (Blute et al, 2007; Wotkowicz et al, 2008). Venovenous bypass is commonly used in these cases but may not be required if adequate collateral flow is present. Throughthisapproach,vascularisolation is achieved in a manner similar to that in B. The latter may reduce bleeding if there is a contentious renal hilum as a result of encasement of the vessels or bulky lymphadenopathy. Vaccination against Streptococcus pneumoniae, Haemophilus influenzae type B, and Neisseria meningitides should be performed preoperatively when splenectomy is likely during nephrectomy (Shatz, 2005; Habermalz et al, 2008). If not already immunized, splenectomized patients should receive these vaccines in the postsurgical setting to prevent sepsis caused by one of these encapsulated organisms (Shatz, 2005; Habermalz et al, 2008). Incomplete excision of a large primary tumor, or debulking, is rarely indicated as survival estimates are only 10% to 20% at 12 months (Dekernion et al, 1978; Karellas et al, 2009). Several early studies suggested that preoperative radiotherapy could improve survival (Cox et al, 1970). A subsequent study by van der Werf-Messing (1973), however, compared results for preoperative therapy with controls and found no survival difference at 5 years. Routine postoperative radiotherapy has not been shown to influence overall survival and can be hazardous because of proximity of small bowel, which is highly radiosensitive. If the thrombus is mobilized below the atrium, sequential vascular control can often be achieved without opening the heart (Ciancio et al, 2010).

Order viagra capsules amex. 15 Crazy Sex Facts No One Told You About.

References

  • Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokineactivated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985;313(23):1485-1492.
  • Redell MS, Ruiz MJ, Gerbing RB, et al. FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report. Blood 2013;121(7):1083- 1093.
  • Duff HJ, Roden DM, Yacobi A, et al: Bretylium: Relations between plasma concentrations and pharmacological actions in high-frequency ventricular arrhythmias, Am J Cardiol 55:395, 1985.
  • Sobrier ML, Attie-Bitach T, Netchine I, et al: Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development, Gene Expr Patterns 5:279n284, 2004.
  • Peghini PL, Katz PO, Bracy NA, et al: Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol 93:763, 1998.